Your browser doesn't support javascript.
loading
Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil.
Tan, Hyon-Xhi; Wragg, Kathleen M; Kelly, Hannah G; Esterbauer, Robyn; Dixon, Benjamin J; Lau, Jillian S Y; Flanagan, Katie L; van de Sandt, Carolien E; Kedzierska, Katherine; McMahon, James H; Wheatley, Adam K; Juno, Jennifer A; Kent, Stephen J.
Afiliação
  • Tan HX; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Wragg KM; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kelly HG; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Esterbauer R; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Dixon BJ; Head and Neck Surgery, Epworth Healthcare, Richmond, Victoria, Australia.
  • Lau JSY; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Flanagan KL; Department of Infectious Diseases, Monash Medical Centre, Melbourne, Victoria, Australia.
  • van de Sandt CE; School of Health Sciences and School of Medicine, University of Tasmania, Launceston, Tasmania, Australia.
  • Kedzierska K; Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
  • McMahon JH; School of Health and Biomedical Science, RMIT University, Melbourne, Victoria, Australia; and.
  • Wheatley AK; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, Tasmania, Australia.
  • Juno JA; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kent SJ; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
J Immunol ; 208(10): 2267-2271, 2022 05 15.
Article em En | MEDLINE | ID: mdl-35487578

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2022 Tipo de documento: Article